Qube Research & Technologies (QRT)
AKRO

Qube Research & Technologies (QRT)’s Akero Therapeutics AKRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150,142
Closed -$6.08M – 3520
2025
Q1 		$6.08M Buy
150,142
+142,102
+1,767% +$6.02M 0.01% 1432
2024
Q4 		$224K Buy
+8,040
New +$243K ﹤0.01% 2809
2024
Q1 		– Sell
-136,828
Closed -$3.19M – 4427
2023
Q4 		$3.19M Buy
+136,828
New +$2.7M 0.01% 1283
2020
Q4 		– Sell
-18,262
Closed -$562K – 1771
2020
Q3 		$562K Buy
+18,262
New +$638K 0.01% 993

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AKRO Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Akero Therapeutics (AKRO) in Q2 2025, closing a stake of 150,142 shares — an estimated $6.08M sold.

Qube Research & Technologies (QRT) first reported a position in AKRO in Q3 2020 and held it in 4 quarters. The position peaked at $6.08M in Q1 2025. 257 funds tracked by Wall St. Rank hold AKRO as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Akero Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 150,142 Akero Therapeutics shares in Q2 2025, an estimated $6.08M.
  • Qube Research & Technologies (QRT) first reported a position in Akero Therapeutics in Q3 2020 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Akero Therapeutics position peaked at $6.08M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.